| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |